TPEX:6578

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

NT$612.9m

Last Updated

2021/06/21 23:35 UTC

Data Sources

Company Financials

Executive Summary

DaBomb Protein Corp. produces and supplies plant peptides in Asia. More Details


Snowflake Analysis

Mediocre balance sheet and overvalued.

Share Price & News

How has DaBomb Protein's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 6578 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 6578's weekly volatility (4%) has been stable over the past year.


Market Performance


7 Day Return

-0.7%

6578

-1.6%

TW Personal Products

-1.3%

TW Market


1 Year Return

-0.2%

6578

-11.6%

TW Personal Products

45.3%

TW Market

Return vs Industry: 6578 exceeded the TW Personal Products industry which returned -8% over the past year.

Return vs Market: 6578 underperformed the TW Market which returned 48.1% over the past year.


Shareholder returns

6578IndustryMarket
7 Day-0.7%-1.6%-1.3%
30 Day4.6%-0.06%5.2%
90 Day-10.5%-6.4%6.3%
1 Year2.3%-0.2%-8.6%-11.6%49.9%45.3%
3 Year-27.3%-32.4%-7.8%-15.1%74.8%55.6%
5 Yearn/a27.2%10.4%138.4%97.3%

Long-Term Price Volatility Vs. Market

How volatile is DaBomb Protein's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is DaBomb Protein undervalued compared to its fair value and its price relative to the market?

0.89x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: 6578 (NT$20.35) is trading above our estimate of fair value (NT$3.6)

Significantly Below Fair Value: 6578 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 6578 is unprofitable, so we can't compare its PE Ratio to the TW Personal Products industry average.

PE vs Market: 6578 is unprofitable, so we can't compare its PE Ratio to the TW market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 6578's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 6578 is good value based on its PB Ratio (0.9x) compared to the TW Personal Products industry average (2.2x).


Future Growth

How is DaBomb Protein forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

18.6%

Forecasted Household industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as DaBomb Protein has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has DaBomb Protein performed over the past 5 years?

-44.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 6578 is currently unprofitable.

Growing Profit Margin: 6578 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 6578 is unprofitable, and losses have increased over the past 5 years at a rate of 44% per year.

Accelerating Growth: Unable to compare 6578's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 6578 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (4.7%).


Return on Equity

High ROE: 6578 has a negative Return on Equity (-2.1%), as it is currently unprofitable.


Financial Health

How is DaBomb Protein's financial position?


Financial Position Analysis

Short Term Liabilities: 6578's short term assets (NT$286.8M) exceed its short term liabilities (NT$126.1M).

Long Term Liabilities: 6578's short term assets (NT$286.8M) exceed its long term liabilities (NT$86.3M).


Debt to Equity History and Analysis

Debt Level: 6578's debt to equity ratio (24.4%) is considered satisfactory.

Reducing Debt: 6578's debt to equity ratio has increased from 9.3% to 24.4% over the past 5 years.

Debt Coverage: 6578's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 6578's interest payments on its debt are well covered by EBIT.


Balance Sheet


Dividend

What is DaBomb Protein current dividend yield, its reliability and sustainability?

0.98%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 6578's dividend (0.98%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (1.98%).

High Dividend: 6578's dividend (0.98%) is low compared to the top 25% of dividend payers in the TW market (5.01%).


Stability and Growth of Payments

Stable Dividend: 6578 is not paying a notable dividend for the TW market, therefore no need to check if payments are stable.

Growing Dividend: 6578 is not paying a notable dividend for the TW market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: 6578 is not paying a notable dividend for the TW market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 6578's dividend in 3 years as they are not forecast to pay a notable one for the TW market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Yu Fen Liu

no data

Tenure

Ms. Yu Fen Liu serves as Chairman and General Manager of DaBomb Protein Corp. Ms. Liu served as the Chairman of Board of Directors in DaBomb Protein Company Limited. Ms. Liu holds EMBA Degree from National...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.6%.


Top Shareholders

Company Information

DaBomb Protein Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: DaBomb Protein Corp.
  • Ticker: 6578
  • Exchange: TPEX
  • Founded: 2001
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: NT$612.930m
  • Shares outstanding: 30.12m
  • Website: https://www.dabombprotein.com

Number of Employees


Location

  • DaBomb Protein Corp.
  • No.52, Gongye 3rd Road
  • Annan District
  • Tainan City
  • 709
  • Taiwan

Listings


Biography

DaBomb Protein Corp. produces and supplies plant peptides in Asia. It offers hydrolyzed soya peptide products, functional peptides, and natural lactobacillus strains under the da bomb brand. The company wa...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/21 23:35
End of Day Share Price2021/06/21 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.